Introducing NGSwab

EGL is proud to announce NGSwab for exome testing; offering the same high quality exome tests with ease of the assisted saliva swab (the Oragene OCD-100 kit). Please see below some common questions.

What is NGSwab?

NGSwab refers to EGL’s assisted saliva sample type. At EGL, we continue to explore options for our patients that make sample collecting easier while not sacrificing quality.

How does it work?

NGSwab utilizes Oragene’s OCD-100 kit to collect saliva from which EGL extracts high quality DNA. For more information on how to use it, please see the video from DNA Genotek below.

OCD-100 Instructions

How is the saliva collected?

Follow the manufacturer’s instructions contained within the collection kit. A simple swab of each inside cheek is all that is required. More details found here.

Are there any downsides of using this sample type?

The quantity of DNA available after extraction may only be enough for the ordered test. In some cases, a new sample may need to be provided for additional testing.

Is this a recommended sample type?

Our recommended sample type for exome testing is blood;however,we offer NGSwab in situations where blood collection might not always be your patient’s best option.

How is this better than the other specimen types?

NGSwab is not necessarily a better collection method; however, it is much easier to collect and a great alternative for patients with limited access to phlebotomy services.

For more questions, please reach out to EGL’s Client Services team at eglcs@egl-eurofins.com.

Director Spotlight

This month we are featuring Dr. Arunkanth Ankala, Genomics Director at EGL. Dr. Ankala is Board Certified in Clinical Molecular Genetics. Dr. Ankala has a PhD in Molecular Biology, from Mississippi State University and M.Sc in Biochemistry from Bharatidasan University, India. Dr. Ankala completed his post-graduate training at Emory University School of Medicine. He has been working at EGL (formerly Emory Genetics Laboratory) since 2014 as a Molecular Genetics Director. Ankala_Headshot edited

Arun has published over 30 peer-reviewed publications that include research papers, review articles, editorials and book chapters. He has also served as an editor for a book on Muscular Dystrophy (ISBN: 978-953-51-0603-6). He has presented at several meetings on current topics such as ‘Implementation and clinical utility of transcriptome sequencing: Experience from neuromuscular disorders’ at American College of Medical Genetics 2016 Meeting. He serves as reviewer for several journals such as Neurology, Neurology Genetics, Genes, Human Mutation and Genetics in Medicine.

Dr. Ankala’s primary clinical research has been the application of exome sequencing technology to molecular diagnosis and the evaluation of its true diagnostic potential. With a thorough understanding of the limitations and potentials of the technology, his research focus lies in developing a more customized, curated and complete next generation sequencing assay. His broader research interest has been the discovery of new disease causing genes associated with different muscular dystrophies and understanding the genotype-phenotype correlation for the variety of known muscular dystrophies.

To learn more about his research and experience in neuromuscular disorder testing, meet him at American Society of Human Genetics Conference 2018, San Diego, CA. Or stop by our booth 1010.